The biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027. The increasing incidence of wounds and ulcers, and growing number of surgical procedures across the world fuel the market growth. Moreover, continuous innovations in wound care products are expected to drive market growth during the forecast period. However, the high cost associated with wound care management hinders the growth of the biofilms treatment market. Biofilms are composed of mixed strains of fungi, bacteria, yeasts, algae, and other microbes.A biofilm develops on the wound surface when certain types of bacteria or fungi adhere to the wound surface and form a matrix over it.
Viscous and shiny substances with unpleasant smell are secreted. The rising diabetes cases and skin injuries due to burns fuel the growth of the biofilms treatment market. The global biofilms treatment market is segmented on the basis of product, wound type, and end user.Based on product, the market is segmented into debridement equipment, gauzes and dressings, grafts and matrices, and other products.
The gauzes and dressings segment held the largest market share in 2019, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.Based on wound type, the market is segmented into traumatic and surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other wounds.
The traumatic and surgical wounds segment held the largest share of the market in 2019.The same segment is anticipated to register the highest CAGR in the market during 2020–2027.
By end user, the biofilms treatment market is segmented into hospitals, home care settings, and other end users. In 2019, the hospitals segment held the largest share of the market. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. Australian Wound Management Association, Canadian Association of Wound Care, and European Wound Management Association are a few of the primary and secondary sources referred to while preparing the report on the biofilms treatment market.
Our reports have been used by over 10K customers, including:
The South & Central America closed systems drug transfer devices market is expected to reach US$ 118.49 million by 2027 from US$ 28.37 million in 2019; it is estimated to grow at a CAGR of 19.6% from 2020 to 2027. The closed systems drug transfer devices market in South & Central America is primarily driven by rise in adoption of chemotherapy...
The Asia Pacific addictions therapeutics market is expected to reach US$ 1,781.09 million by 2027 from US$ 1,060.33 million in 2019. The market is estimated to grow with a CAGR of 6.8% from 2020 to 2027. The growth of the market is attributed to the rising approval of new drugs and launch of digital therapeutics to treat addiction, and...
257 pages •
By The Business Research Company
• Dec 2020
Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth provides the strategists, marketers and senior management with the critical information they need to assess the global anti-viral drug therapy market. Description: Where is the largest and fastest growing...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
The global benign prostatic hyperplasia treatment market is projected to reach USD 14.1 billion by 2026 from USD 10.8 billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven owing to the increasing prevalence of benign prostatic hyperplasia, the rising preference for minimally invasive surgeries, increasing...
181 pages •
By The Business Research Company
• Dec 2020
Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market. Description: Where is the largest and fastest growing...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies...
242 pages •
By The Business Research Company
• Dec 2020
CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market. Description: Where is the largest and fastest growing market for the CAR-T therapy...
Therapy
World
APAC
Health Expenditure
Cancer Incidence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.